This inventor holds 1 USPTO granted patent. Top assignee: Daewoong Pharmaceutical Co., Ltd.. Active years: 1994.
Company Filing History:
Years Active: 1994
Title: Moo J Sung: Innovator in Cephem Compounds
Introduction
Moo J Sung is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephem compounds. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Moo J Sung holds a patent for 3-substituted cephem compounds. This invention represents a crucial step in the development of new antibiotics, which can potentially address various bacterial infections. The patent highlights his commitment to improving healthcare through innovative solutions.
Career Highlights
Moo J Sung is currently employed at Daewoong Pharmaceutical Co., Ltd. His role at the company allows him to collaborate with other talented professionals in the pharmaceutical industry. His work has not only contributed to the company's success but has also positioned him as a key figure in the field of drug development.
Collaborations
Moo J Sung has worked alongside colleagues such as Chi Jang Moon and Sae C Park. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research and development efforts.
Conclusion
Moo J Sung's contributions to the field of pharmaceuticals, particularly through his patent on cephem compounds, demonstrate his innovative spirit and commitment to improving healthcare. His work at Daewoong Pharmaceutical Co., Ltd. and collaborations with esteemed colleagues underscore his importance in the industry.